Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial
Titel:
Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial
Auteur:
Morgan, Robert J. Synold, Timothy W. Longmate, Jeffrey A. Quinn, David I. Gandara, David Lenz, Heinz-Josef Ruel, Christopher Xi, Bixin Lewis, Michael D. Colevas, A. Dimitrios Doroshow, James Newman, Edward M.